COVID-19 patients who could benefit from Paxlovid find price shock

Submitted by mike kraft on

COVID-19 patients who could most benefit from Paxlovid still aren’t getting it - UPI.com Sticker shock has stunned thousands of Americans sick with COVID-19 since late December, as Pfizer shifted to commercial sales of Paxlovid. Before then, the federal government covered the cost of the drug. UPI

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Public Health
Economics
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -